CORC

在结果中检索

CORC

浏览/检索结果: 共303条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Shi, Yuankai;  Zhang, Qing Yuan;  Hong, Xiaonan;  Wang, Zhen;  Gao, Yuhuan
收藏  |  浏览/下载：11/0  |  提交时间：2022/12/23
Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026
作者:  Shi, Yuankai;  Zhang, Shucai;  Hu, Xingsheng;  Feng, Jifeng;  Ma, Zhiyong
收藏  |  浏览/下载：36/0  |  提交时间：2020/12/24
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial 期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1
作者:  Zhang, Wei;  Gao, Yuhuan;  Jin, Zhengming;  Zhou, Jianfeng;  Jin, Chuan
收藏  |  浏览/下载：44/0  |  提交时间：2019/12/05
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018) 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4
作者:  Xiao, Xiubin;  Bao, Huizheng;  Wang, Ningju;  Ren, Hanyun;  Cen, Xinan
收藏  |  浏览/下载：56/0  |  提交时间：2019/12/05
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 5
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study 期刊论文
TARGETED ONCOLOGY, 2019, 卷号: 14, 期号: 2
作者:  Hong, Xiaonan;  Song, Yuqin;  Huang, Huiqiang;  Bai, Bing;  Zhang, Huilai
收藏  |  浏览/下载：23/0  |  提交时间：2019/12/05
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial 期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Sun, Yan;  Wang, Liwei
收藏  |  浏览/下载：112/0  |  提交时间：2019/12/05
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study 期刊论文
CHEST, 2019, 卷号: 155, 期号: 1
作者:  Zhai, Zhenguo;  Kan, Quancheng;  Li, Weimin;  Qin, Xinyu;  Qu, Jieming
收藏  |  浏览/下载：58/0  |  提交时间：2019/12/05
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study 期刊论文
CHEST, 2019, 卷号: 155, 页码: 114-122
作者:  Zhai, Zhenguo;  Kan, Quancheng;  Li, Weimin;  Qin, Xinyu;  Qu, Jieming
收藏  |  浏览/下载：58/0  |  提交时间：2019/11/19
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303. 期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:  Si Xiaoyan;  Zhang Li;  Wang Hanping;  Zhang Xiaotong;  Wang Mengzhao
收藏  |  浏览/下载：34/0  |  提交时间：2019/11/19

©版权所有 ©2017 CSpace - Powered by CSpace